Renal Artery Denervation View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2015-02-02

AUTHORS

Thomas Zeller , Costas Tsioufis , Felix Mahfoud

ABSTRACT

Hypertension is highly prevalent and one of the most frequent chronic diseases worldwide. Approximately 10 % of patients with high blood pressure are resistant to drug treatment in the presence of three or more antihypertensive drugs of different classes, including a diuretic, at maximal or the highest tolerated dose. Sympathetic overstimulation is one of the key components of resistant hypertension. Percutaneous catheter-based transluminal renal ablation (RDN) has emerged as a new approach to achieve sustained blood pressure reduction in patients with drug-resistant hypertension. Currently established radiofrequency- or ultrasound-based devices thermally damage the perivascular tissue of the renal artery interrupting the efferent and afferent sympathetic nerve bundles. Several position papers summarized the current evidence, unmet needs, and practical recommendations for the application of this therapeutic strategy in clinical practice. Given that there is no established intra-procedural control of ablation success, interventionalists have to be familiar with the aspects related to the anatomy and imaging of the renal arteries, the distribution of renal sympathetic fibers, the special equipment necessary for RDN, and the procedural details in order to maximize the success and minimize potential complications. This chapter summarizes the clinical background of essential hypertension, in particular resistant hypertension, currently published or presented data, and technical aspects of renal denervation. In 2013, commercially available (CE marked) renal denervation devices are described in detail. More... »

PAGES

3959-3988

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-642-37078-6_125

DOI

http://dx.doi.org/10.1007/978-3-642-37078-6_125

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1033840362


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Abteilung Kardiologie & Angiology II, Universit\u00e4ts-Herzzentrum Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, 79189, Bad Krozingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.418466.9", 
          "name": [
            "Abteilung Kardiologie & Angiology II, Universit\u00e4ts-Herzzentrum Freiburg \u2013 Bad Krozingen, S\u00fcdring 15, 79189, Bad Krozingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zeller", 
        "givenName": "Thomas", 
        "id": "sg:person.01306206724.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsioufis", 
        "givenName": "Costas", 
        "id": "sg:person.0723511665.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723511665.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universit\u00e4tsklinikum des Saarlandes, Kirrberger Str. 1, 66421, Homburg/Saar, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411937.9", 
          "name": [
            "Klinik f\u00fcr Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universit\u00e4tsklinikum des Saarlandes, Kirrberger Str. 1, 66421, Homburg/Saar, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mahfoud", 
        "givenName": "Felix", 
        "id": "sg:person.0746500146.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746500146.21"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2015-02-02", 
    "datePublishedReg": "2015-02-02", 
    "description": "Hypertension is highly prevalent and one of the most frequent chronic diseases worldwide. Approximately 10 % of patients with high blood pressure are resistant to drug treatment in the presence of three or more antihypertensive drugs of different classes, including a diuretic, at maximal or the highest tolerated dose. Sympathetic overstimulation is one of the key components of resistant hypertension. Percutaneous catheter-based transluminal renal ablation (RDN) has emerged as a new approach to achieve sustained blood pressure reduction in patients with drug-resistant hypertension. Currently established radiofrequency- or ultrasound-based devices thermally damage the perivascular tissue of the renal artery interrupting the efferent and afferent sympathetic nerve bundles. Several position papers summarized the current evidence, unmet needs, and practical recommendations for the application of this therapeutic strategy in clinical practice. Given that there is no established intra-procedural control of ablation success, interventionalists have to be familiar with the aspects related to the anatomy and imaging of the renal arteries, the distribution of renal sympathetic fibers, the special equipment necessary for RDN, and the procedural details in order to maximize the success and minimize potential complications. This chapter summarizes the clinical background of essential hypertension, in particular resistant hypertension, currently published or presented data, and technical aspects of renal denervation. In 2013, commercially available (CE marked) renal denervation devices are described in detail.", 
    "editor": [
      {
        "familyName": "Lanzer", 
        "givenName": "Peter", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-642-37078-6_125", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-642-37077-9", 
        "978-3-642-37078-6"
      ], 
      "name": "PanVascular Medicine", 
      "type": "Book"
    }, 
    "keywords": [
      "resistant hypertension", 
      "renal artery", 
      "drug-resistant hypertension", 
      "sympathetic nerve bundles", 
      "renal sympathetic fibers", 
      "renal denervation devices", 
      "blood pressure reduction", 
      "frequent chronic diseases", 
      "high blood pressure", 
      "renal artery denervation", 
      "sympathetic overstimulation", 
      "renal denervation", 
      "renal ablation", 
      "sympathetic fibers", 
      "blood pressure", 
      "essential hypertension", 
      "ablation success", 
      "antihypertensive drugs", 
      "potential complications", 
      "chronic diseases", 
      "drug treatment", 
      "clinical background", 
      "nerve bundles", 
      "hypertension", 
      "therapeutic strategies", 
      "current evidence", 
      "clinical practice", 
      "unmet need", 
      "perivascular tissue", 
      "pressure reduction", 
      "procedural details", 
      "ultrasound-based device", 
      "denervation", 
      "patients", 
      "artery", 
      "diuretics", 
      "complications", 
      "efferents", 
      "overstimulation", 
      "disease", 
      "dose", 
      "interventionalists", 
      "technical aspects", 
      "drugs", 
      "treatment", 
      "position paper", 
      "tissue", 
      "ablation", 
      "radiofrequency", 
      "imaging", 
      "special equipment", 
      "maximal", 
      "practical recommendations", 
      "RDN", 
      "evidence", 
      "recommendations", 
      "key component", 
      "control", 
      "background", 
      "success", 
      "reduction", 
      "different classes", 
      "pressure", 
      "presence", 
      "need", 
      "practice", 
      "bundles", 
      "aspects", 
      "data", 
      "strategies", 
      "fibers", 
      "components", 
      "new approach", 
      "devices", 
      "detail", 
      "approach", 
      "chapter", 
      "class", 
      "distribution", 
      "equipment", 
      "order", 
      "applications", 
      "paper"
    ], 
    "name": "Renal Artery Denervation", 
    "pagination": "3959-3988", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1033840362"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-642-37078-6_125"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-642-37078-6_125", 
      "https://app.dimensions.ai/details/publication/pub.1033840362"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-05-10T10:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/chapter/chapter_249.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-642-37078-6_125"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-37078-6_125'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-37078-6_125'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-37078-6_125'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-37078-6_125'


 

This table displays all metadata directly associated to this object as RDF triples.

163 TRIPLES      23 PREDICATES      107 URIs      100 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-642-37078-6_125 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N33112888acd74ae6af216269525508d8
4 schema:datePublished 2015-02-02
5 schema:datePublishedReg 2015-02-02
6 schema:description Hypertension is highly prevalent and one of the most frequent chronic diseases worldwide. Approximately 10 % of patients with high blood pressure are resistant to drug treatment in the presence of three or more antihypertensive drugs of different classes, including a diuretic, at maximal or the highest tolerated dose. Sympathetic overstimulation is one of the key components of resistant hypertension. Percutaneous catheter-based transluminal renal ablation (RDN) has emerged as a new approach to achieve sustained blood pressure reduction in patients with drug-resistant hypertension. Currently established radiofrequency- or ultrasound-based devices thermally damage the perivascular tissue of the renal artery interrupting the efferent and afferent sympathetic nerve bundles. Several position papers summarized the current evidence, unmet needs, and practical recommendations for the application of this therapeutic strategy in clinical practice. Given that there is no established intra-procedural control of ablation success, interventionalists have to be familiar with the aspects related to the anatomy and imaging of the renal arteries, the distribution of renal sympathetic fibers, the special equipment necessary for RDN, and the procedural details in order to maximize the success and minimize potential complications. This chapter summarizes the clinical background of essential hypertension, in particular resistant hypertension, currently published or presented data, and technical aspects of renal denervation. In 2013, commercially available (CE marked) renal denervation devices are described in detail.
7 schema:editor Nbaa94483c9d146e4b2cbb4999c6153fe
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf N9d2d78bf01f3406582f9466983d09a63
12 schema:keywords RDN
13 ablation
14 ablation success
15 antihypertensive drugs
16 applications
17 approach
18 artery
19 aspects
20 background
21 blood pressure
22 blood pressure reduction
23 bundles
24 chapter
25 chronic diseases
26 class
27 clinical background
28 clinical practice
29 complications
30 components
31 control
32 current evidence
33 data
34 denervation
35 detail
36 devices
37 different classes
38 disease
39 distribution
40 diuretics
41 dose
42 drug treatment
43 drug-resistant hypertension
44 drugs
45 efferents
46 equipment
47 essential hypertension
48 evidence
49 fibers
50 frequent chronic diseases
51 high blood pressure
52 hypertension
53 imaging
54 interventionalists
55 key component
56 maximal
57 need
58 nerve bundles
59 new approach
60 order
61 overstimulation
62 paper
63 patients
64 perivascular tissue
65 position paper
66 potential complications
67 practical recommendations
68 practice
69 presence
70 pressure
71 pressure reduction
72 procedural details
73 radiofrequency
74 recommendations
75 reduction
76 renal ablation
77 renal artery
78 renal artery denervation
79 renal denervation
80 renal denervation devices
81 renal sympathetic fibers
82 resistant hypertension
83 special equipment
84 strategies
85 success
86 sympathetic fibers
87 sympathetic nerve bundles
88 sympathetic overstimulation
89 technical aspects
90 therapeutic strategies
91 tissue
92 treatment
93 ultrasound-based device
94 unmet need
95 schema:name Renal Artery Denervation
96 schema:pagination 3959-3988
97 schema:productId N670ab8ef7bab489ea10a61f05982c467
98 Nbfbf100201ab4cb8a4b9da718b1a3ec4
99 schema:publisher N4c1b1ae7cefa44beb5d56f2508eacc67
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033840362
101 https://doi.org/10.1007/978-3-642-37078-6_125
102 schema:sdDatePublished 2022-05-10T10:43
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N41a9a6c673b54ceb9f123d03b5e866ba
105 schema:url https://doi.org/10.1007/978-3-642-37078-6_125
106 sgo:license sg:explorer/license/
107 sgo:sdDataset chapters
108 rdf:type schema:Chapter
109 N33112888acd74ae6af216269525508d8 rdf:first sg:person.01306206724.74
110 rdf:rest Nbe8a901e28364c7096324901990f8c76
111 N41a9a6c673b54ceb9f123d03b5e866ba schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N4c1b1ae7cefa44beb5d56f2508eacc67 schema:name Springer Nature
114 rdf:type schema:Organisation
115 N64c0284c7be144cf88aac07d84213c33 rdf:first sg:person.0746500146.21
116 rdf:rest rdf:nil
117 N670ab8ef7bab489ea10a61f05982c467 schema:name doi
118 schema:value 10.1007/978-3-642-37078-6_125
119 rdf:type schema:PropertyValue
120 N8d6e75f5fc1040ea8f2b897a3f9d1d6b schema:familyName Lanzer
121 schema:givenName Peter
122 rdf:type schema:Person
123 N9d2d78bf01f3406582f9466983d09a63 schema:isbn 978-3-642-37077-9
124 978-3-642-37078-6
125 schema:name PanVascular Medicine
126 rdf:type schema:Book
127 Nbaa94483c9d146e4b2cbb4999c6153fe rdf:first N8d6e75f5fc1040ea8f2b897a3f9d1d6b
128 rdf:rest rdf:nil
129 Nbe8a901e28364c7096324901990f8c76 rdf:first sg:person.0723511665.79
130 rdf:rest N64c0284c7be144cf88aac07d84213c33
131 Nbfbf100201ab4cb8a4b9da718b1a3ec4 schema:name dimensions_id
132 schema:value pub.1033840362
133 rdf:type schema:PropertyValue
134 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
135 schema:name Medical and Health Sciences
136 rdf:type schema:DefinedTerm
137 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
138 schema:name Cardiorespiratory Medicine and Haematology
139 rdf:type schema:DefinedTerm
140 sg:person.01306206724.74 schema:affiliation grid-institutes:grid.418466.9
141 schema:familyName Zeller
142 schema:givenName Thomas
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74
144 rdf:type schema:Person
145 sg:person.0723511665.79 schema:affiliation grid-institutes:None
146 schema:familyName Tsioufis
147 schema:givenName Costas
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723511665.79
149 rdf:type schema:Person
150 sg:person.0746500146.21 schema:affiliation grid-institutes:grid.411937.9
151 schema:familyName Mahfoud
152 schema:givenName Felix
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746500146.21
154 rdf:type schema:Person
155 grid-institutes:None schema:alternateName First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece
156 schema:name First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece
157 rdf:type schema:Organization
158 grid-institutes:grid.411937.9 schema:alternateName Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Kirrberger Str. 1, 66421, Homburg/Saar, Germany
159 schema:name Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Kirrberger Str. 1, 66421, Homburg/Saar, Germany
160 rdf:type schema:Organization
161 grid-institutes:grid.418466.9 schema:alternateName Abteilung Kardiologie & Angiology II, Universitäts-Herzzentrum Freiburg – Bad Krozingen, Südring 15, 79189, Bad Krozingen, Germany
162 schema:name Abteilung Kardiologie & Angiology II, Universitäts-Herzzentrum Freiburg – Bad Krozingen, Südring 15, 79189, Bad Krozingen, Germany
163 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...